Modradoc006, An Oral Docetaxel Formulation In Combination With Ritonavir (Modradoc006/R), In Metastasized Castration-Resistant Prostate Cancer (Mcrpc): A Multicenter Phase I Study

Marit Vermunt,Debbie Robbrecht,Lot Devriese,Julie Janssen,Marianne Keessen,Ferry Eskens,Jos H. Beijnen,Niven Mehra,Andre M. Bergman

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 3|浏览46

暂无评分

摘要

79Background: ModraDoc006 is a novel formulation of docetaxel and to enhance bioavailability, this tablet is co-administered with ritonavir (r), an inhibitor of cytochrome p450 3A4 and P-glycoprote...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要